Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · December 09, 2022

Efficacy of Triamcinolone Acetonide Suprachoroidal Injectable Suspension in Patients With Uveitic Macular Edema

Ophthalmology and Therapy


Additional Info

Ophthalmology and Therapy
Triamcinolone Acetonide Suprachoroidal Injectable Suspension for Uveitic Macular Edema: Integrated Analysis of Two Phase 3 Studies
Ophthalmol Ther 2022 Nov 18;[EPub Ahead of Print], S Yeh, CR Henry, B Kapik, TA Ciulla

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading